- Home
- TRAW vs JZXN Comparison
TRAW vs JZXN Comparison
Compare TRAW & JZXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRAW
- JZXN
- Stock Information
- Founded
- TRAW 1998
- JZXN 2017
- Country
- TRAW United States
- JZXN China
- Employees
- TRAW N/A
- JZXN N/A
- Industry
- TRAW
- JZXN Retail-Auto Dealers and Gas Stations
- Sector
- TRAW
- JZXN Consumer Discretionary
- Exchange
- TRAW NYSE
- JZXN Nasdaq
- Market Cap
- TRAW 15.0M
- JZXN 15.3M
- IPO Year
- TRAW 2013
- JZXN 2021
- Fundamental
- Price
- TRAW $5.54
- JZXN $1.30
- Analyst Decision
- TRAW
- JZXN
- Analyst Count
- TRAW 0
- JZXN 0
- Target Price
- TRAW N/A
- JZXN N/A
- AVG Volume (30 Days)
- TRAW 9.7K
- JZXN 16.8K
- Earning Date
- TRAW 11-20-2024
- JZXN 11-22-2024
- Dividend Yield
- TRAW N/A
- JZXN N/A
- EPS Growth
- TRAW N/A
- JZXN N/A
- EPS
- TRAW N/A
- JZXN N/A
- Revenue
- TRAW $226,000.00
- JZXN $7,597,423.00
- Revenue This Year
- TRAW $2.90
- JZXN N/A
- Revenue Next Year
- TRAW N/A
- JZXN N/A
- P/E Ratio
- TRAW N/A
- JZXN N/A
- Revenue Growth
- TRAW N/A
- JZXN 81.94
- 52 Week Low
- TRAW $4.44
- JZXN $1.00
- 52 Week High
- TRAW $27.50
- JZXN $67.60
- Technical
- Relative Strength Index (RSI)
- TRAW 52.69
- JZXN 38.69
- Support Level
- TRAW $4.92
- JZXN $1.32
- Resistance Level
- TRAW $5.96
- JZXN $1.51
- Average True Range (ATR)
- TRAW 0.28
- JZXN 0.16
- MACD
- TRAW 0.17
- JZXN -0.01
- Stochastic Oscillator
- TRAW 61.82
- JZXN 0.00
About TRAW TRAWS PHARMA INC
Traws Pharma Inc is a biopharmaceutical company focused on developing antivirals for influenza, COVID and other respiratory infections and narazaciclib.
About JZXN Jiuzi Holdings Inc.
Jiuzi Holdings Inc operates as a franchise under the brand name Jiuzi. It sells new energy vehicles in third-fourth tier cities in China. The firm also sells plug-in electric vehicles on demand from vehicle buyers. Its business segments are sales of NEVs and Franchisees services. The company generates a majority of its revenue from the NEVs segment. Geographically, the firm operates in China.